COVID-Steroid 2 Trial for Patients

COVID Steroid 2 compares high versus low dose dexamethasone (a steroid) for the treatment of patients with COVID-19.

Dexamethasone has shown promise as a potential treatment for COVID-19. With this trial we aim to see which dose is most effective for critically ill patients.

Trial Sponsor

Professor, MD, Anders Perner
University Hospital Copenhagen, Rigshospitalet

Useful Documents

Overview of Recruitment